Lizamarie Bachier | GCI

Georgia's Online Cancer Information Center


back

Find A Doctor

Blood and Marrow Transplant Program
https://www.northside.com/services/research.

Lizamarie Bachier

Specialty
Medical Oncology, Hematology
Trial Cancers
Cancer-Related Syndrome, Hodgkin Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS)
Affiliations
The Blood and Marrow Transplant Group of Georgia Northside Hospital
Education

Medical School: University of Puerto Rico

Active Clinical Trial Sites in Georgia

Northside Hospital Cancer Institute

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355 (p)
www.northside.com

driving directions



Northside Hospital Cancer Institute - Bone Marrow Transplant (BMT)

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-851-8523 (p)


driving directions

Clinical Trials
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Cancer-Related Syndrome

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Hodgkin Lymphoma

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Leukemia

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Lymphoma

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Cancer Type: Multiple Myeloma

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Cancer Type: Myelodysplastic Syndromes (MDS)
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Find Cancer Care

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

 

Georgia CORE reduces the burden of cancer in our state through research, education, and advocacy.